Success Story: From RFE to Victory—A Triumph for Infectious Disease Surveillance and Public Health Preparedness
Client’s Testimonial:
"Right from the initial evaluation through the preparation of my petition and the RFE response, it has been an absolute pleasure working with Chen. Their team is exceptionally prompt in communication and works collaboratively to ensure that your petition reflects both your subject matter expertise and their legal expertise.
I feel incredibly grateful to have worked with such an outstanding team of attorneys and highly recommend them. Your chances of approval are greatly enhanced when you work with such a professional and knowledgeable team. They are truly among the best in their field."
On February 11th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Epidemiologist in the Field of Public Health (Approval Notice).
General Field: Public Health
Position at the Time of Case Filing: Epidemiologist
Country of Origin: India
State of Residence at the Time of Filing: Washington
Approval Notice Date: February 11th, 2026
Processing Time: 5 months, 3 days (Premium Processing Requested)
Case Summary:
“She demonstrated that integrated contact tracing systems work across diverse high-risk community settings, providing objective epidemiological monitoring tools and reducing reliance on fragmented response approaches. This also prevents delayed outbreak identification and costly uncontrolled transmission events.”
This expert validation highlights the profound impact of the client's work. Recently, North America Immigration Law Group (Chen Immigration Law Associates) represented this distinguished researcher, whose endeavor focuses on strengthening infectious disease surveillance systems and enhancing applied epidemiologic analyses.
Strengthening National Public Health Infrastructure
The client’s proposed endeavor centers on integrating epidemiologic and laboratory datasets to support rapid outbreak detection, antimicrobial resistance monitoring, and vaccine-policy decision-making in the United States. This work is of critical national importance, as it directly addresses pathogens, which are recognized as priority antibiotic-resistant threats. Additionally, the client’s work enhances United States preparedness for future pandemics.
Beyond academic contributions, the client’s work has seen extensive real-world implementation. Her protocols have been implemented by a major public health laboratory to streamline specimen testing prioritization and improve data exchange during outbreak investigations. Furthermore, she led the development of a coordinated contact tracing system that enabled the timely detection of outbreaks across high-risk settings, including hospitals, schools, and correctional facilities.
Overcoming the RFE Challenge
The petition initially received a Request for Evidence (RFE) that questioned the substantial merit of the proposed endeavor. We meticulously crafted a response grounded in the preponderance of the evidence standard.
To address the concerns raised by USCIS, our legal team provided a comprehensive rebuttal:
- Detailed Personal Statement: We guided the client in providing an updated statement that explained in detail how her research directly responds to urgent national public health priorities.
- Verification of Federal Support: We highlighted that the client’s work has been supported by funding from the CDC and its Epidemiology and Laboratory Capacity (ELC) Program. We argued that because this funding is reserved for work that protects national health security and controls disease outbreaks, it served as objective evidence of the endeavor’s merit.
- Documentation of Practical Implementation: We submitted new testimonials. These documents showed that her epidemiologic protocols were actively implemented to streamline testing prioritization and improve data exchange during critical outbreak investigations.
A Record of Proven Scholarly Influence
The client’s standing in the field is further reinforced by strong objective metrics:
- Authorship: She has published 3 peer-reviewed journal articles in premier venues.
- Citation Metrics: Her research has amassed 30 citations, with one paper ranking among the top 10% and another among the top 20% of most-cited articles in Clinical Medicine for their respective publication years.
- Systemic Impact: Her surveillance work has been adopted by all 50 U.S. states to improve the timeliness and comprehensiveness of tracking for specific vaccine-preventable diseases.
By constructing a narrative that clearly aligned the client's expertise in infectious disease with the United States' urgent need for evidence-based disease control, we successfully secured an NIW approval on February 11th, 2026. NAILG is proud to have guided this exceptional epidemiologist and researcher to a successful outcome, ensuring she can continue her vital work in the United States.